[PGC-1alpha controls neuromuscular junction and offers a novel therapeutic target in Duchenne dystrophy?].
Arnold
Anne-Sophie
AS
Physiology Institute, Université de Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Suisse. a.arnold@access.uzh.ch
D006360:Heat-Shock Proteins / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D009135:Muscular Diseases / Q000188:drug therapy / Q000503:physiopathology; D020388:Muscular Dystrophy, Duchenne / Q000188:drug therapy* / Q000503:physiopathology*; D000071248:Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; D014157:Transcription Factors / Q000187:drug effects / Q000502:physiology*
D006360:Heat-Shock Proteins; C486497:PPARGC1A protein, human; D000071248:Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; D014157:Transcription Factors